PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $338,000 | -13.3% | 400,000 | 0.0% | 0.01% | -7.1% |
Q2 2019 | $390,000 | -22.6% | 400,000 | 0.0% | 0.01% | -26.3% |
Q1 2019 | $504,000 | -61.1% | 400,000 | 0.0% | 0.02% | -68.9% |
Q4 2018 | $1,296,000 | -1.4% | 400,000 | -15.1% | 0.06% | +19.6% |
Q2 2018 | $1,315,000 | -59.0% | 471,321 | -30.2% | 0.05% | -62.8% |
Q1 2018 | $3,206,000 | -18.5% | 675,000 | 0.0% | 0.14% | -23.5% |
Q4 2017 | $3,935,000 | +316.4% | 675,000 | +50.0% | 0.18% | +306.8% |
Q3 2017 | $945,000 | -55.1% | 450,000 | 0.0% | 0.04% | -58.5% |
Q2 2017 | $2,106,000 | -40.2% | 450,000 | 0.0% | 0.11% | -47.8% |
Q1 2017 | $3,519,000 | -36.2% | 450,000 | 0.0% | 0.20% | -45.0% |
Q4 2016 | $5,517,000 | -21.4% | 450,000 | 0.0% | 0.37% | -16.1% |
Q3 2016 | $7,016,000 | +39.4% | 450,000 | +8.4% | 0.44% | +18.0% |
Q2 2016 | $5,034,000 | +11.1% | 415,000 | -11.7% | 0.37% | -1.8% |
Q1 2016 | $4,531,000 | – | 470,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 3,804,027 | $17,803,000 | 2.95% |
HARBOURVEST PARTNERS LLC | 440,627 | $2,062,000 | 0.89% |
NEA Management Company, LLC | 3,556,778 | $16,646,000 | 0.61% |
Rock Springs Capital Management LP | 450,000 | $2,106,000 | 0.11% |
Bain Capital Public Equity Management, LLC | 263,498 | $1,233,000 | 0.07% |
ELEMENT CAPITAL MANAGEMENT LLC | 65,973 | $309,000 | 0.06% |
Hillhouse Capital Management | 865,923 | $4,053,000 | 0.06% |
SABBY MANAGEMENT, LLC | 125,151 | $586,000 | 0.04% |
Marshall Wace North America L.P. | 684,124 | $3,421,000 | 0.02% |
FNY Partners Fund LP | 20,127 | $94,000 | 0.02% |